Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News solutions by stc partners with Mavenir for Saudi Arabia’s first commercial Open RAN network In a significant development for the telecommunications sector in Saudi Arabia, solutions by stc, the forefront of digital… byPallavi MadhirajuFebruary 28, 2024